Iron Status and Risk of Stroke
Open Access
- 1 December 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (12) , 2815-2821
Abstract
Background and Purpose—: Both iron deficiency and excess have been associated with stroke risk in observational studies. However, such associations may be attributable to confounding from environmental factors. This study uses the Mendelian randomization technique to overcome these limitations by investigating the association between genetic variants related to iron status and stroke risk. Methods—: A study of 48 972 subjects performed by the Genetics of Iron Status consortium identified genetic variants with concordant relations to 4 biomarkers of iron status (serum iron, transferrin saturation, ferritin, and transferrin) that supported their use as instruments for overall iron status. Genetic estimates from the MEGASTROKE consortium were used to investigate the association between the same genetic variants and stroke risk. The 2-sample ratio method Mendelian randomization approach was used for the main analysis, with the MR-Egger and weighted median techniques used in sensitivity analyses. Results—: The main results, reported as odds ratio (OR) of stroke per SD unit increase in genetically determined iron status biomarker, showed a detrimental effect of increased iron status on stroke risk (serum iron OR, 1.07; 95% CI, 1.01–1.14; [log-transformed] ferritin OR, 1.18; 95% CI, 1.02–1.36; and transferrin saturation OR, 1.06; 95% CI, 1.01–1.11). A higher transferrin, indicative of lower iron status, was also associated with decreased stroke risk (OR, 0.92; 95% CI, 0.86–0.99). Examining ischemic stroke subtypes, we found the detrimental effect of iron status to be driven by cardioembolic stroke. These results were supported in statistical sensitivity analyses more robust to the inclusion of pleiotropic variants. Conclusions—: This study provides Mendelian randomization evidence that higher iron status is associated with increased stroke risk and, in particular, cardioembolic stroke. Further work is required to investigate the underlying mechanism and whether this can be targeted in preventative strategies.Keywords
This publication has 38 references indexed in Scilit:
- Acute Ischemic Stroke Secondary to Iron Deficiency Anemia: A Case ReportCase Reports in Neurological Medicine, 2012
- Genetic variants in novel pathways influence blood pressure and cardiovascular disease riskNature, 2011
- Severe iron deficiency anaemia and ischaemic stroke in childrenArchives of Disease in Childhood, 2010
- Risk Factors for Ischaemic StrokeInternational Journal of Stroke, 2008
- Iron Stores and HFE Genotypes Are Not Related to Increased Risk of Ischemic StrokeCerebrovascular Diseases, 2007
- Hereditary hemochromatosis genotypes and risk of ischemic strokeNeurology, 2007
- Serum Ferritin Is a Risk Factor for Stroke in Postmenopausal WomenStroke, 2005
- Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjectsNutrition, Metabolism and Cardiovascular Diseases, 2005
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Hemolobin and the Risk of Cerebral Infarction: The Framingham StudyStroke, 1972